[{"Assets_0_Q1_USD":"103034000000.0","CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q1_USD":"0.54","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"0.6","EarningsPerShareDiluted_1_Q1_USD":"0.59","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162000000000.0","MinorityInterest_0_Q1_USD":"65000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"3812000000.0","NetIncomeLoss_1_Q1_USD":"1278000000.0","OfficialName":"Bristol-Myers Squibb Company Common Stock","PaymentsOfDividends_1_Q1_USD":"1185000000.0","ProfitLoss_1_Q1_USD":"1283000000.0","RevenuesConverted_1_Q1_USD":"11648000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"31645000000.0","StockholdersEquity_0_Q1_USD":"31580000000.0","Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"2164000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"2146000000.0","filed":"20220429","footnote":null,"form":"10-Q","fp":"Q1","fy":"2022.0","name":"BRISTOL MYERS SQUIBB CO","period":"20220331","qtrs":"0","uom":"USD"}]